MET and cancer: In conclusion, the model shown here introduces the proof of concept that ATM haploinsufficiency, which is found quite frequently in human cancers and alone is not able to limit the effectiveness of genotoxic pharmacological agents, such as PARP inhibitors, can be circumvented by interfering with other pathways (e.g., MET) leading to mitosis regulation.